Form 4 for TXG 10x Genomics, Inc.
Accepted 2021-09-03 00:00:00 ET · period of report 2021-09-01 · accession 0001209191-21-054901 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-09-03 | 2021-09-01 | TXG | STUELPNAGEL JOHN R | Dir | S - Sale | $177.48 | -5,000 | 381.3K | -1% | -$887.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-09-01 | S | D | 1,104 | $178.34 | 376,912 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $178.06 to $178.88. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 2 | Common | Class A Common Stock | 2021-09-01 | S | D | 2,300 | $177.62 | 378,016 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $177.06 to $178.035. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 3 | Common | Class A Common Stock | 2021-09-01 | S | D | 1,000 | $176.36 | 380,316 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $175.93 to $176.90. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 4 | Common | Class A Common Stock | 2021-09-01 | S | D | 296 | $179.15 | 376,616 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $179.12 to $179.19. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 5 | Common | Class A Common Stock | 2021-09-01 | S | D | 300 | $175.36 | 381,316 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $174.87 to $175.615. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |